Coordinated by GU Ventures
Interested in Our Work or Seeking Guidance and Support?
Please don’t hesitate to reach out to us and the project organizations below. Let’s connect!
I’m interested in:
Stephanie Mattsson, Director Venture Development, CCRM
With a comprehensive background in the life sciences, Stephanie boasts profound expertise in strategic venture development and a solid track record in international business. She has over 5 years of experience in regenerative medicine where she supported both private and public companies with strategy and business development as well as state-funded initiatives.
Fredrik Wångsell, PhD, Research Advisor, OligoNova
More than 15 years industrial experience within research and development, focus on target identification, lead generation, translational science, IND-enabling and preclinical toxicological evaluation to support clinical development. The core activities within OligoNova and New Modality Support are to increase the value and prepare the assets for commercialization.
Carl-Peter Mattsson, Coordinator NMS, Investment Director, GU Ventures
International outlook with a strong Venture Capital network and Life Science expertise. He has extensive experience of international business projects across many industries, project partners, and financing strategies, and over 25 years of Venture Capital experience, including both direct and fund investments at national and international levels.